SOD2 and hyperlipidemia: As shown in Figures 6(a), 6(e), and 6(f), the decreased SOD2 and SOD3 levels induced by hyperlipidemia were recovered by BYD dose-dependently; these results suggested that BYD improved erythrocyte osmotic fragility due to its antilipid peroxidation effect.